Redefining Left Ventricular Assist Device Indications and Strategies

Affiliations

Comment

Muddassir Mehmood. JAMA Cardiol. 2021.

. 2021 Jan 1;6(1):119-120.

doi: 10.1001/jamacardio.2020.4320.

¹ Division of Cardiology, Department of Medicine, The University of Tennessee Medical Center, Knoxville.

No abstract available

Comment in

Redefining Left Ventricular Assist Device Indications and Strategies-Reply.
Mehra MR, Goldstein DJ. Mehra MR, et al. JAMA Cardiol. 2021 Jan 1;6(1):120-121. doi: 10.1001/jamacardio.2020.4323. JAMA Cardiol. 2021. PMID: 32965468 No abstract available.

Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC Jr, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR. Goldstein DJ, et al. JAMA Cardiol. 2020 Apr 1;5(4):411-419. doi: 10.1001/jamacardio.2019.5323. JAMA Cardiol. 2020. PMID: 31939996 Free PMC article. Clinical Trial.